Inhibition of trans-retinoic acid-resistant human breast cancer cell growth by retinoid X receptor-selective retinoids

Molecular and Cellular Biology

Volumn 17, Issue 11, 1997, Pages 6598-6608

  Wu, Qiao ^a   Dawson, Marcia I ^b   Zheng, Yun ^a   Hobbs, Peter D ^b   Agadir, Anissa ^a   Jong, Ling ^b   Li, Yin ^a   Liu, Ru ^a   Lin, Bingzhen ^a   Zhang, Xiao Kun ^a  

^a BURNHAM INSTITUTE   (United States)

^b SRI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOIC ACID; RETINOID X RECEPTOR;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER RESEARCH; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; DOSE RESPONSE; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

EID: 0030764346     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.17.11.6598     Document Type: Article

References (73)

1. Bartsch, D., B. Boye, C. Baust, H. zur Hausen, and E. Schwarz. 1992. Retinoic acid-mediated repression of human papillomavirus 18 transcription and different ligand regulation of the retinoic acid receptor β gene in non-tumorigenic and tumorigenic HeLa hybrid cells. EMBO J. 11:2283-2291.
2. Boccardo, F., L. Canobbio, M. Resasco, A. U. Decensi, G. Pastorino, and F. Brema. 1990. Phase II study of tamoxifen and high-dose retinyl acetate in patients with advanced breast cancer. J. Cancer Res. Clin. Oncol. 116:503-506.
3. Cassidy, J., M. Lippman, A. Lacroix, and G. Peck. 1982. Phase II trial of 13-cis-retinoic acid in metastatic breast cancer. Eur. J. Cancer Clin. Oncol. 18:925-928.
4. Chen, J.-Y., J. Clifford, C. Zusi, J. Starrett, D. Tortolani, J. Ostrowski, P. R. Reczek, P. Chambon, and H. Gronemeyer. 1996. Two distinct actions of retinoid-receptor ligands. Nature 382:819-822.
5. Clifford, J. L., M. Petkovich, P. Chambon, and R. Lotan. 1990. Modulation by retinoids of mRNA levels for nuclear retinoic acid receptors in murine melanoma cells. Mol. Endocrinol. 4:1546-1555.
6. Davis, K. D., T. J. Berrodin, J. E. Stelmach, J. D. Winkler, and M. A. Lazar. 1994. Endogenous retinoid X receptors can function as hormone receptors in pituitary cells. Mol. Cell. Biol. 14:7105-7110.
7. Dawson, M. I., W. R. Chao, P. Ping, L. Jong, P. D. Hobbs, C. Rudd, T. C. Quick, R. M. Niles, X.-K. Zhang, A. Lombarde, K. R. Ely, B. Shroot, and J. A. Fontana. 1995. Correlation of retinoid binding affinity to RARα with retinoid inhibition of growth of estrogen receptor-positive MCF-7 mammary carcinoma cells. Cancer Res. 55:4446-4451.
8. Dawson, M. I., L. Jong, P. D. Hobbs, J. F. Cameron, W. R. Chao, M. Pfahl, M. O. Lee, and B. Shroot. 1995. Conformational effects on retinoid receptor selectivity. 2. Effects of retinoid bridging group on retinoid X receptor activity and selectivity. J. Med. Chem. 38:3368-3383.
9. Dejean, A., L. Bougueleret, K.-H. Grzeschik, and P. Tiollais. 1986. Hepatitis B virus DNA integration in a sequence homologous to v-erb-A and steroid receptor genes in a hepatocellular carcinoma. Nature 322:70-72.
10. de The, H., M. del Mar Vivanco-Ruiz, P. Tiollais, H. Stunnenberg, and A. Dejean. 1990. Identification of a retinoic acid responsive element in the retinoic acid receptor β gene. Nature 343:177-180.
11. Fanjul, A. N., D. Delia, M. A. Pierotti, D. Rideout, J. Qiu, and M. Pfahl. 1996. 4-Hydroxyphenyl retinamide is a highly selective activator of retinoid receptors. J. Biol. Chem. 271:22441-22446.
12. Fanjul, A. N., H. Bouterfa, M. Dawson, and M. Pfahl. 1996. Potential role for retinoic acid receptor-γ in the inhibition of breast cancer cells by selective retinoids and interferons. Cancer Res. 56:1571-1577.
13. Fontana, J. A. 1987. Interaction of retinoids and tamoxifen on the inhibition of human mammary carcinoma cell proliferation. Exp. Cell. Biol. 55:136-144.
14. Fontana, J. A., P. D. Hobbs, and M. I. Dawson. 1988. Inhibition of mammary carcinoma growth by retinoidal benzoic acid derivatives. Exp. Cell. Biol. 56:254-263.
15. Forman, B. M., K. Umesono, J. Chen, and R. M. Evans. 1995. Unique response pathways are established by allosteric interactions among receptors. Cell 81:541-550.
16. Gebert, J. F., N. Moghal, J. V. Frangioni, D. J. Sugarbaker, and B. G. Neel. 1991. High frequency of retinoic acid receptor β abnormalities in human lung cancer. Oncogene 6:1859-1868.
17. Giuseppe, G., M. I. Dawson, X.-K. Zhang, C. J. Thiele. Activation of three distinct RXR/RAR heterodimers induces growth arrest and differentiation of neuroblastoma cells. J. Biol. Chem., in press.
18. Gottardis, M. M., E. D. Bischoff, M. A. Shirley, M. A. Wagoner, W. W. Lamph, and R. A. Heyman. 1996. Chemoprevention of mammary carcinoma by LGD1069 (Targretin): an RXR-selectivc ligand. Cancer Res. 56:5566-5570.
19. Grubbs, C. J., R. C. Moon, M. B. Sporn, and D. L. Newton. 1977. Inhibition of mammary cancer by retinyl methyl ether. Cancer Res. 37:599-602.
20. Gudas, L. J., M. B. Sporn, and A. B. Roberts. 1994. Cellular biology and biochemistry of the retinoids, p. 443-520. In M. B. Sporn, A. B. Roberts, and D. S. Goodman (ed.). The retinoids. Raven Press, New York, N.Y.
21. Hazel, T. G., D. Nathans, and L. F. Lau. 1988. A gene inducible by serum growth factors encodes a member of the steroid and thyroid hormone receptor superfamily. Proc. Natl. Acad. Sci. USA 85:8444-8448.
22. Hoffmann, B., J. M. Lehmann, X.-K. Zhang, T. Hermann, G. Graupner, and M. Pfahl. 1990. A retinoic acid receptor-specific element controls the retinoic acid receptor-β promoter. Mol. Endocrinol. 4:1734-1743.
23. Houle, B., F. Ledue, and W. E. C. Bradley. 1991. Implication of RARβ in epidermoid (squamous) carcinoma cells. Exp. Cell Res. 195:163-170.
24. Houle, B., C. Rochette-Egly, and W. E. C. Bradley. 1993. Tumor-suppressive effect of the retinoic acid receptor β in human epidermoid lung cancer cells. Proc. Natl. Acad. Sci. USA 90:985-989.
25. Hu, L., D. L. Crowe, J. G. Rheinwald, P. Chambon, and L. Gudas. 1991. Abnormal expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell carcinoma cell lines. Cancer Res. 51:3972-3981.
26. Kagechika, H., E. Kawachi, Y. Hashimoto, T. Himi, and K. Shudo. 1988. Retinobenzoic acids. 1. Structure-activity relationships of aromatic amides with retinoidal activity. J. Med. Chem. 31:2182-2192.
27. Kagechika, H., E. Kawachi, G. Saito, H. Fukusawa, Y. Hashimoto, and K. Shudo. 1995. Comparison of differentiation between NB4 and HL-60 cells induced by retinoids, abstr. B-27. In Abstracts of mechanisms of action of retinoids, vitamin D, and steroid hormones. AACR Special Conference, British Columbia, Canada.
28. Kamei, Y., L. Xu, T. Heinzel, J. Torchia, R. Kurokawa, B. Gloss, S.-C. Lin, R. A. Heyman, D. W. Rose, C. K. Glass, and M. G. Rosenfeld. 1996. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85:403-414.
29. Kastner, P., M. Mark, and P. Chambon. 1995. Nonsteroid nuclear receptors: what are genetic studies telling us about their role in real life? Cell 83:859-869.
30. 3 or antiestrogen to inhibit T-47D human breast cancer cell proliferation. J. Steroid Biochem. Mol. Biol. 39:455-460.
31. Kurokawa, R., J. DiRenzo, M. Boehm, J. Sugarman, B. Gloss, M. G. Rosenfeld, R. A. Heyman, and C. K. Glass. 1994. Regulation of retinoid signalling by receptor polarity and allosteric binding. Nature 371:528-531.
32. Lala, D. S., R. Mukherjee, I. G. Schulman, S. S. Canan Koch, L. J. Dardashti, A. M. Nadzan, G. E. Croston, R. M. Evans, and R. A. Heyman. 1996. Activation of specific RXR heterodimers by an antagonist of RXR homodimers. Nature 383:450-453.
33. Lee, M.-O., Y. Liu, and X.-K. Zhang. 1995. A retinoic acid response element that overlaps an estrogen response element mediates multihormonal sensitivity in transcriptional activation of the lactoferrin gene. Mol. Cell. Biol. 15:4194-4207.
34. Li, X.-S., Z.-M. Shao, M. H. Shekh, J. L. Eiseman, D. Sentz, A. M. Jetten, J.-H. Chen, M. I. Dawson, S. Aisner, A. K. Rishi, P. Gutierrez, L. Schnapper, and J. A. Fontana. 1995. Retinoic acid nuclear receptor β inhibits breast carcinoma anchorage independent growth. J. Cell. Physiol. 165:449-458.
35. Liu, Y., M.-O. Lee, H.-G. Wang, Y. Li, Y. Hashimoto, M. Klaus, J. C. Reed, and X.-K. Zhang. 1996. RARβ mediates the growth inhibitory effect of retinoic acid by inducing cell apoptosis in human breast cancer cells. Mol. Cell. Biol. 16:1138-1149.
36. Liu, Z.-G., S. W. Smith, K. A. McLaughlin, L. M. Schwartz, and B. A. Osborne. 1994. Apoptotic signals delivered through the T-cell receptor of a T-cell hybrid require the immediate-early gene nur77. Nature 367:281-284.
37. Lotan, R. 1981. Effect of vitamin A and its analogs (retinoids) on normal and neoplastic cells. Biochim. Biophys. Acta 605:33-91.
38. Lotan, R., X. C. Xu, S. M. Lippman, J. Y. Ro, J. S. Lee, J. J. Lee, and W. K. Hong. 1995. Suppression of retinoic acid receptor-β in premalignant oral lesions and its upregulation by isotretinoin. N. Engl. J. Med. 332:1405-1410.
39. Mangelsdorf, D. J., and R. M. Evans. 1995. The RXR heterodimers and orphan receptors. Cell 83:841-850.
40. Milbrandt, J. 1988. Nerve growth factor induces a gene homologous to the glucocorticoid receptor gene. Neuron 1:183-188.
41. Minucci, S., M. Leid, R. Toyama, J.-P. Saint-Jeannet, V. J. Peterson, V. Horn, J. E. Ishmael, N. Bhattacharyya, A. Dey, I. B. Dawid, and K. Ozato. 1997. Retinoid X receptor (RXR) within the RXR-retinoic acid receptor heterodimer hinds its ligand and enhances retinoid-dependent gene expression. Mol. Cell. Biol. 17:644-655.
42. Miyaura, N., and A. Suzuki. 1995. Palladium-catalyzed cross-coupling reactions of organoboron compounds. Chem. Rev. 95:2457-2483.
43. Modiano, M., W. Dalton, S. Lippman, L. Jotte, A. R. Booth, and F. L. Meyskens, Jr. 1990. Phase II study of fenretinide (N-[4-hydroxyphenyl]retinamide) in advanced breast cancer and melanoma. Invest. New Drugs 8:317-319.
44. Moon, R. C., and R. G. Mehta. 1990. Chemoprevention of mammary cancer by retinoids. Basic Life Sci. 52:213-224.
45. Moon, R. C., J. F. Pritchard, R. G. Mehta, C. T. Monides, C. F. Thomas, and N. M. Dinger. 1989. Suppression of rat mammary cancer development by N-(4-hydroxyphenyl)retinamide (4-HPR) following surgical removal of first palpable tumor. Carcinogenesis 10:1645-1649.
46. Moon, R. C., H. J. Thompson, P. J. Becci, C. J. Grubbs, R. J. Gander, D. L. Newton, J. M. Smith, S. L. Phillips, W. R. Henderson, L. T. Mullen, C. C. Brown, and M. B. Sporn. 1979. N-(4-Hydroxyphenyl)retinamide, a new retinoid for prevention of breast cancer in the rat. Cancer Res. 39:1339-1346.
47. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65:55-63.
48. Nagy, L., V. A. Thomazy, G. L. Shipley, L. Fesus, W. Lamph, R. A. Heyman, R. A. Chandraratna, and P. J. Davies. 1995. Activation of retinoid X receptors induces apoptosis in HL-60 cell lines. Mol. Cell. Biol. 15:3540-3551.
49. Nervi, C., T. M. Volleberg, M. D. George, A. Zelent, P. Chambon, and A. M. Jetten. 1991. Expression of nuclear retinoic acid receptors in normal tracheobronchial cells and in lung carcinoma cells. Exp. Cell Res. 195:163-170.
50. Perlmann, T., and L. Jansson. 1995. A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and Nurr1. Genes Dev. 9:769-782.
51. Roberts, A. B., and M. B. Sporn. 1984. Cellular biology and biochemistry of the retinoids, p. 209-286. In M. B. Sporn, A. B. Roberts, and D. S. Goodman (ed.), The retinoids. Academic Press, Orlando, Fla.
52. Roman, S. D., C. L. Clarke, R. E. Hall, I. E. Alexander, and R. L. Sutherland. 1992. Expression and regulation of retinoic acid receptors in human breast cancer cells. Cancer Res. 52:2236-2242.
53. Roy, B., R. Taneja, and P. Chambon. 1995. Synergistic activation of retinoic acid (RA)-responsive genes and induction of embryonal carcinoma cell differentiation by an RA receptor α (RARα)-, RARβ-or RARγ-selective ligand in combination with a retinoid X receptor-specific ligand. Mol. Cell. Biol. 15:6481-6487.
54. Seewaldt, V. L., B. S. Johnson, M. B. Parker, S. J. Collins, and K. Swisshelm. 1995. Expression of retinoic acid receptor β mediates retinoic acid-induced growth arrest and apoptosis in breast cancer cells. Cell Growth Differ. 6: 1077-1088.
55. Sheikh, M. S., Z. M. Shao, J. C. Chen, A. Hussain, A. M. Jetten, and J. A. Fontana. 1993. Estrogen receptor-negative breast cancer cells transfected with the estrogen receptor exhibit increased RARα gene expression and sensitivity to growth inhibition by retinoic acid. J. Cell. Biochem. 53:394-404.
56. Sheikh M. S., Z. M. Shao, X. S. Li, M. Dawson, A. M. Jetten, S. Wu, B. A. Conley, M. Garcia, H. Rochefort, and J. A. Fontana. 1994. Retinoid-resistant estrogen receptor-negative human breast carcinoma cells transfected with retinoic acid receptor-α acquire sensitivity to growth inhibition by retinoids. J. Biol. Chem. 269:21440-21447.
57. Spanjaard R. A., A. Sugawara, M. Ikeda, and W. W. Chin. 1995. Evidence that retinoid X receptors mediate retinoid-dependent transcriptional activation of the retinoic acid receptor β gene in S91 melanoma cells. J. Biol. Chem. 270:17429-17436.
58. Sucov, H. M., K. K. Murakami, and R. M. Evans. 1990. Characterization of an autoregulated response element in the mouse retinoic acid receptor type β gene. Proc. Natl. Acad. Sci. USA 87:5392-5396.
59. Swisshelm, K., K. Ryan, X. Lee, H. C. Taou, M. Peacocke, and R. Sager. 1994. Down-regulation of retinoic acid receptor β in mammary carcinoma cell lines and its up-regulation in senescing normal mammary epithelial cells. Cell Growth Differ. 5:133-141.
60. Taneja, R., B. Roy, J.-L. Plassat, C. F. Zusi, J. Ostrowski, P. R. Reczek, and P. Chambon. 1996. Cell-type and promoter-context dependent retinoic acid receptor (RAR) redundancies for RARβ2 and Hoxa-1 activation in F9 and P19 cells can be artefactually generated by gene knockouts. Proc. Natl. Acad. Sci. USA 93:6197-6202.
61. van der Burg, B., B.-J. M. van der Leede, L. Kwakkenbos-Isbrucker, S. Salverda, S. W. de Laat, and P. T. van der Saag. 1993. Retinoid acid resistance of estradiol-independent breast cancer cells coincides with diminished retinoic acid receptor function. Mol. Cell. Endocrinol. 91:149-157.
62. van der Leede, B. J., G. E. Folkers, C. E. van den Brink, P. T. van der Saag, and B. van der Burg. 1995. Retinoic acid receptor a isoform is induced by estradiol and confers retinoic acid sensitivity in human breast cancer cells. Mol. Cell. Endocrinol. 109:77-86.
63. Wetherall N. T., and C. M. Taylor. 1986. The effects of retinoid treatment and antiestrogens on the growth of T47D human breast cancer cells. Eur. J. Cancer Clin. Oncol. 22:53-59.
64. Willy, P. J., K. Umesono, E. S. Ong, R. M. Evans, R. A. Heyman, and O. J. Mangelsdorf. 1995. LXR, a nuclear receptor that defines a distinct retinoid response pathway. Genes Dev. 9:1033-1045.
65. Wilson, T. E., T. J. Fahrner, M. Johnston, and J. Milbrandt. 1991. Identification of the DNA binding site for NGFI-B by genetic selection in yeast. Science 252:1296-1300.
66. Woronicz, J. D., B. Cainan, V. Ngo, and A. Winoto. 1994. Requirement for the orphan steroid receptor nur77 in apoptosis of T-cell hybridomas. Nature 367:277-281.
67. Wu Q., Y. Li, R. Liu, A. Agadir, M.-O. Lee, Y. Liu, and X.-K. Zhang. 1997. Modulation of retinoic acid sensitivity in lung cancer cells by a dynamic balance of nur77 and COUP-TF orphan receptors and their heterodimerization. EMBO J. 16:1656-1669.
68. Zhang, X.-K., B. Hoffmann, P. B. Tran, G. Graupner, and M. Pfahl. 1992. Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors. Nature 355:441-446.
69. Zhang X.-K., J. Lehmann, B. Hoffmann, M. I. Dawson, J. Cameron, G. Graupner, T. Hermann, P. Tran, and M. Pfahl. 1992. Homodimer formation of retinoid X receptor induced by 9-cis retinoic acid. Nature 358:587-591.
70. Zhang, X.-K., Y. Liu, M. O. Lee, and M. Pfahl. 1994. A specific defect in the retinoic acid receptor associated with human lung cancer cell lines. Lancer Res. 54:5663-5669.
71. Zhang, X.-K., and M. Pfahl. 1993. Hetero-and homodimeric receptors in thyroid hormone and vitamin A action. Receptor 3:183-191.
72. Zhang X-K., G. Salbert, M.-O. Lee, and M. Pfahl. 1994. Mutations that alter ligand-induced switches and dimerization activities in the retinoid X receptor. Mol. Cell. Biol. 14:4311-4323.
73. Zhao, Z., Z. P. Zhang, D. R. Soprano, and K. J. Soprano. 1995. Effect of 9-cis-retinoic acid on growth and RXR expression in human breast cancer cells. Exp. Cell Res. 219:555-561.